Who makes [14C]-MD1003?

[14C]-MD1003 is developed by MedDay Pharmaceuticals SA.

What are the side effects of [14C]-MD1003?

Common side effects include Back pain, Presyncope.

Last reviewed 2026-04-20 · How we verify

[14C]-MD1003

MedDay Pharmaceuticals SA · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	[14C]-MD1003
Sponsor	MedDay Pharmaceuticals SA
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

Back pain
Presyncope

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[14C]-MD1003 CI brief — competitive landscape report
[14C]-MD1003 updates RSS · CI watch RSS
MedDay Pharmaceuticals SA portfolio CI